Home › Funds › SUPERSTRING CAPITAL MANAGEMENT LP › CLDX
SUPERSTRING CAPITAL MANAGEMENT LP position in CLDX
CELLDEX THERAPEUTICS INC NEW · Health Care
SUPERSTRING CAPITAL MANAGEMENT LP reported holding 287,583 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q2 2026 13F filing — a position valued at US$10.7M, representing 6.76% of its reported portfolio and ranking #4 among its reported holdings. SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLDX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How SUPERSTRING CAPITAL MANAGEMENT LP's CLDX position evolved
SUPERSTRING CAPITAL MANAGEMENT LP first disclosed a stake in CLDX in Q4 2025 at 88,308 shares (US$2.4M). The position peaked in Q2 2026 at 287,583 shares, worth US$10.7M. Across 3 filings, SUPERSTRING CAPITAL MANAGEMENT LP increased the stake 2 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 287,583 shares valued at US$10.7M — an increase of 107,535 shares quarter over quarter.. Notable position changes include a 104% increase in Q1 2026 (shares rose 17% over the following quarter), a 60% increase in Q2 2026 (shares fell 13% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 88.31K | $2.40M | New |
| Q1 2026 | 180.05K | $5.71M | Add |
| Q2 2026 | 287.58K | $10.70M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLDX and 13F data
CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 44 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$198.1M), Deep Track Capital, LP (US$109.4M), Logos Global Management LP (US$78.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLDX
- Kynam Capital Management, LP 5.32M sh · $198.07M · Q2 2026
- Deep Track Capital, LP 2.94M sh · $109.37M · Q2 2026
- Logos Global Management LP 2.10M sh · $78.14M · Q2 2026
- Eversept Partners, LP 1.79M sh · $66.45M · Q2 2026
- Commodore Capital LP 1.35M sh · $50.23M · Q2 2026
- Bellevue Group AG 1.20M sh · $44.65M · Q2 2026
- BAKER BROS. ADVISORS LP 1.18M sh · $44.00M · Q2 2026
- Novo Holdings A/S 1.02M sh · $38.14M · Q2 2026
- Elmind Capital, LP 990.00K sh · $36.84M · Q2 2026
- Foresite Capital Management VI LLC 879.71K sh · $32.73M · Q2 2026
- Affinity Asset Advisors, LLC 700.00K sh · $26.05M · Q2 2026
- Rock Springs Capital Management LP 699.15K sh · $26.02M · Q2 2026
More on SUPERSTRING CAPITAL MANAGEMENT LP
FAQ
How long has SUPERSTRING CAPITAL MANAGEMENT LP held CLDX?
SUPERSTRING CAPITAL MANAGEMENT LP has disclosed CLDX holdings in 3 of the last 3 reported quarters, going back to Q4 2025.
What is SUPERSTRING CAPITAL MANAGEMENT LP's current position in CLDX?
As of Q2 2026, SUPERSTRING CAPITAL MANAGEMENT LP holds 287.58K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $10.70M, representing 6.76% of its reported portfolio and ranking #4.
Has SUPERSTRING CAPITAL MANAGEMENT LP been buying or selling CLDX?
In the latest 13F filing (Q2 2026), SUPERSTRING CAPITAL MANAGEMENT LP increased its position in CLDX. The position peaked in Q2 2026 at 287.58K shares.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, Logos Global Management LP, among 44 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.